Morgan Stanley Initiates Sana Biotechnology(SANA.US) With Buy Rating, Announces Target Price $12
Analysts Are Bullish on These Healthcare Stocks: Tenaya Therapeutics (TNYA), Sana Biotechnology (SANA)
Sana Biotechnology: Strong Buy Rating Amidst Promising Pipeline and Solid Financials
Sana Biotechnology Price Target Raised to $15.00/Share From $8.00 by Citigroup
Sana Biotechnology Analyst Ratings
HC Wainwright & Co. Maintains Buy on Sana Biotechnology, Lowers Price Target to $11
Sana Biotechnology: A Buy Rating on Innovative T1D Treatments and Promising Clinical Study Projections
Sana Biotechnology (SANA) Receives a Hold From TD Cowen
Bank of America Securities Remains a Buy on Sana Biotechnology (SANA)
Sana Biotechnology Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Sana Biotechnology, Maintains $12 Price Target
Buy Rating Affirmed for Sana Biotechnology Amidst Strong Clinical Progress and Solid Financials
JMP Securities Maintains Market Outperform on Sana Biotechnology, Raises Price Target to $15
Sana Biotechnology Analyst Ratings
Sana Biotechnology: Promising Clinical Prospects and Buy Rating Justified by Upcoming Data Readouts
Analysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA) and Sana Biotechnology (SANA)
HC Wainwright & Co. Upgrades Sana Biotechnology to Buy, Announces $12 Price Target
Sana Biotechnology Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Masimo (MASI), Sana Biotechnology (SANA)
Buy Rating for Sana Biotechnology Amidst Promising Developments and Strong Financials
No Data
No Data